dh image

Government questions innovation uptake by doctors

February 28, 2014
Medical Communications, Sales and Marketing ABPI, Hunt, NHS, PPRS, UK, doctors

The government has launched a consultation which aims to establish whether doctors are being held back from using innovative treatments, …

Witty image

GSK’s Witty loses bonus over China scandal

February 28, 2014
Medical Communications, Sales and Marketing China, GSK, Witty, sales, sir andrew

GlaxoSmithKline’s chief executive Sir Andrew Witty received bonuses “lower than they otherwise might have been” last year due to the …

Packer Forbes Communications adds managing director

February 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Packer Forbes, joella webber

Comms agency Packer Forbes Communications is strengthening its leadership team by appointing Joella Webber as managing director. Webber who was …

Alimta image

NICE rejects Alimta

February 28, 2014
Sales and Marketing Alimta, Cancer, NHS, NICE, NSCLC, lilly, pemetrexed

Eli Lilly is coming to terms with rejection by NICE after the cost watchdog said it would not recommend Alimta …

Novartis image

Novartis extends trial transparency

February 27, 2014
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency

Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.

MPs concerned about care.data

February 27, 2014
Medical Communications, Sales and Marketing Dorrell, HSCIC, MPs, NHS, UK, care data, care.data, data

MPs have expressed concerns about security in the delayed NHS care.data programme which will see medical information routinely swapped between …

novartis image

Novartis to axe Horsham site

February 27, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Horsham, Novartis, closure, cuts, research, restructure

Novartis has confirmed that it will cease all of its pharmaceutical operations at its Horsham, West Sussex site this year. …

Biotech industry failed by UK, says UCB

February 27, 2014
Research and Development, Sales and Marketing Cimzia, NHS, UCB, biotech, doliveux, tellier, vimpat

The UK biotechnology industry has ‘missed the boat’ and not fulfilled its potential, according to outgoing UCB chief executive Roch …

dave_henderson_ipa_judge

Best of Health Awards judges appointed

February 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Best of Health, IPA, henderson

The 2014 IPA Best of Health Awards which highlight the top creative advertising agencies in the industry has named the …

Mid staffs image

Mid Staffs to be ‘dissolved’

February 27, 2014
Sales and Marketing Hunt, Mid Staffs, NHS, NHS England, tsas

The scandal-hit Mid Staffordshire NHS Foundation Trust is to be dissolved, after health secretary Jeremy Hunt accepted the recommendation of …

Esbriet image

InterMune scores in lung trial

February 26, 2014
Research and Development, Sales and Marketing Esbriet, FDA, IPF, InterMune, fvc, lung

InterMune has taken another step on its lengthy road to get the US regulator to approve its drug Esbriet for …

BMS image

BMS/AZ fat disorder drug gains FDA approval

February 26, 2014
Research and Development, Sales and Marketing AstraZeneca, BMS, FDA, hep C, metreleptin, myalept

Bristol-Myers Squibb and partner AstraZeneca have been granted FDA approval for a new drug to treat rare and potentially fatal …

rupert_gowrley

Bupa hires MHP Health head

February 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BUPA, gowrley, mhp health

Rupert Gowrley is leaving his role as joint head at MHP Health in order to start with Bupa as its …

lilly image

Lilly’s diabetes drug matches Victoza

February 26, 2014
Research and Development, Sales and Marketing EMA, FDA, Victoza, dulaglutide, lilly

Eli Lilly’s once-weekly diabetes candidate dulaglutide has matched Novo Nordisk’s established once-daily Victoza (liraglutide) when it comes to lowering blood …

FDA: India needs more inspectors

February 25, 2014
Manufacturing and Production FDA, India, generics, hamburg

The Food and Drug Administration is to put more inspectors on the ground in India, following a visit there by …

Samsung focussing increasingly on health tech

February 25, 2014
Medical Communications, Sales and Marketing Apple, Samsung, digital, health tech, innovation lab, smartwatch

Samsung has partnered with a US university to create a digital health innovation laboratory whilst also unveiling some new health-tracking …

jean-christophe_tellier

UCB names next chief executive

February 25, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, tellier

Biopharma firm UCB has confirmed its current chief executive Roch Doliveux is to be replaced by Jean-Christophe Tellier. Tellier (pictured) …

Yervoy image

NICE restricts Yervoy use

February 25, 2014
Sales and Marketing BMS, Cancer, NHS, NICE, Yervoy, melanoma

Bristol-Myers Squibb has been dealt a blow by NICE after the UK cost watchdog recommended that the use of skin …

FDA image

FDA given $20 million for generic testing

February 24, 2014
Manufacturing and Production, Sales and Marketing ADHD, FDA, generics, hamburg

The FDA has been given $20 million to help it assess generic treatments, a group of drugs that makes up …

Europe poised for generic Symbicort

February 24, 2014
Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics

The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …

The Gateway to Local Adoption Series

Latest content